The effects of the new synthetic drugs mephedrone, methylone, naphyrone and 5,6-methylenedioxy-2-aminoindane (MDAI) in rats

被引：0
|
作者：
Palenicek, T. [1 ]
Tyls, F. [1 ]
Fujakova, M. [1 ]
Lhotkova, E. [1 ]
Kaderabek, L. [1 ]
Kubesova, A. [1 ]
机构：
[1] Prague Psychiat Ctr, Lab Biochem & Brain Patophysiol, Prague 8, Czech Republic
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2013年 / 23卷
关键词：
D O I：
10.1016/S0924-977X(13)70911-8
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.6.c.013
引用
收藏
页码：S572 / S573
页数：2
相关论文
共 7 条
  • [1] Study on the metabolism of 5,6-methylenedioxy-2-aminoindane (MDAI) in rats: identification of urinary metabolites
    Zidkova, Monika
    Linhart, Igor
    Balikova, Marie
    Himl, Michal
    Vana, Lubomir
    Vetyska, Michal
    Palenicek, Tomas
    Lhotkova, Eva
    Dusek, Martin
    XENOBIOTICA, 2017, 47 (06) : 505 - 514
  • [2] Emerging toxicity of 5,6-methylenedioxy-2-aminoindane (MDAI): Pharmacokinetics, behaviour, thermoregulation and LD50 in rats
    Palenicek, Tomas
    Lhotkova, Eva
    Zidkova, Monika
    Balikova, Marie
    Kuchar, Martin
    Himl, Michal
    Miksatkova, Petra
    Cegan, Martin
    Vales, Karel
    Tyls, Filip
    Horsley, Rachel R.
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2016, 69 : 49 - 59
  • [3] Study on the metabolism of 5,6-methylenedioxy-2-aminoindane (MDAI) in rats: identification of urinary metabolites (vol 47, pg 505, 2016)
    Zidkova, M.
    Linhart, I
    Balikova, M.
    Himl, M.
    Vana, L.
    Vetyska, M.
    Palenicek, T.
    Lhotkova, E.
    Dusek, M.
    XENOBIOTICA, 2017, 47 (06) : X - X
  • [4] 5,6-Methylenedioxy-2-aminoindane: from laboratory curiosity to legal high'
    Gallagher, Cathal T.
    Assi, Sulaf
    Stair, Jacqueline L.
    Fergus, Suzanne
    Corazza, Ornella
    Corkery, John M.
    Schifano, Fabrizio
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2012, 27 (02) : 106 - 112
  • [5] Application of surface enhanced Raman scattering to the solution based detection of a popular legal high, 5,6-methylenedioxy-2-aminoindane (MDAI)
    Mabbott, Samuel
    Alharbi, Omar
    Groves, Kate
    Goodacre, Royston
    ANALYST, 2015, 140 (13) : 4399 - 4406
  • [6] Acute psychotropic, autonomic, and endocrine effects of 5,6-methylenedioxy-2-aminoindane (MDAI) compared with 3,4-methylenedioxymethamphetamine (MDMA) in human volunteers: A self-administration study
    Angerer, Verena
    Schmid, Yasmin
    Franz, Florian
    Gnann, Heike
    Speer, Jan Manuel
    Gnann, Anke
    Helmecke, Stephan
    Buchwald, Armin
    Brandt, Simon D.
    Passie, Torsten
    Liechti, Matthias E.
    Auwaerter, Volker
    DRUG TESTING AND ANALYSIS, 2024, 16 (09) : 1002 - 1011
  • [7] MDAI (5,6-methylenedioxy-2-aminoindane; 6,7-dihydro-5H-cyclopenta[f][1,3]benzodioxol-6-amine; "sparkle'; "mindy') toxicity: a brief overview and update
    Corkery, John M.
    Elliott, Simon
    Schifano, Fabrizio
    Corazza, Ornella
    Ghodse, A. Hamid
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2013, 28 (04) : 345 - 355
1